Literature DB >> 416679

Evaluation of endoscopic retrograde cholangiopancreatography and angiography in the diagnosis of pancreatic carcinoma.

P C Freeny, T J Ball.   

Abstract

A series of 118 patients with suspected pancreatic disease was studied by endoscopic retrograde cholangiopancreatography (ERCP). Angiography was subsequently performed in 30 of these patients. ERCP was 95% accurate in the prospective diagnosis of pancreatic carcinoma. This study suggests that angiography is valuable in determining tumor resectability following ERCP diagnosis of pancreatic carcinoma. Angiography may obviate the need for exploratory laparotomy in patients with unresectable tumors and encourage aggressive treatment of resectable lesions. Patients with a high clinical suspicion of pancreatic disease should have angiography if the ERCP is normal, equivocal, or there is a cannulation failure.

Entities:  

Mesh:

Year:  1978        PMID: 416679     DOI: 10.2214/ajr.130.4.683

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Accuracy of endoscopic retrograde cholangiopancreatography (ERCP) in differentiating benign and malignant pancreatic disease.

Authors:  M P Frick; J F O'Leary; H C Walker; R L Goodale
Journal:  Gastrointest Radiol       Date:  1982

2.  ERCP-guided percutaneous fine-needle pancreatic biopsy.

Authors:  P C Freeny; R Kidd; T J Ball
Journal:  West J Med       Date:  1980-04

3.  Angiographic evaluation of the abnormal endoscopic pancreatogram.

Authors:  J Ariyama; H Shirakabe; M Sumida; C I Bartram
Journal:  Gastrointest Radiol       Date:  1979-08-15

4.  Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage.

Authors:  V Savarino; C Mansi; L Bistolfi; P Zentilin; G Celle
Journal:  Dig Dis Sci       Date:  1983-12       Impact factor: 3.199

Review 5.  A study of 122 cases of pancreatic cancer diagnosed by endoscopic retrograde cholangiopancreatography (ERCP).

Authors:  Y M Moon; W H Kim; S T Shin; C Y Chon; S I Lee; J K Kang; I S Park; H J Choi
Journal:  Korean J Intern Med       Date:  1986-07       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.